Clinical Trials Browser

Diarrhea × Temozolomide × Clear all

NCT00093353 2010-10-15

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Phase 1 Completed

Diarrhea, Neuroblastoma, Drug-Related Side Effects and Adverse Reactions